Marc Sintek, MD
Interventional Cardiology · Saint Louis, MONPI 1700049129
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (44.4%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Philips North America LLC at 39.0% of the total. Among interventional cardiology clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 384 payments — averaging $309.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Philips North America LLC$46K
- Edwards Lifesciences$41K
- Shockwave Medical, Inc$13K
- Boston Scientific$7K
- Biotronik Inc.$6K
- Abiomed$2K
- plus $4K from 13 others
Across 59 payments — averaging $8279.88 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Edwards Lifesciences$206K
- Boston Scientific$171K
- Abbott$56K
- Philips North America LLC$55K
What the payments were for
- Consulting fees$52,75144%
- Speaking & faculty fees$35,73330%
- Travel & lodging$10,6489%
- Food & beverage$19,56916%
- Education$160%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Philips North America LLC | 88 | $46,241 |
| Edwards Lifesciences | 141 | $41,382 |
| Shockwave Medical, Inc | 24 | $12,841 |
| Boston Scientific | 45 | $6,803 |
| Biotronik Inc. | 19 | $5,893 |
| Abiomed | 18 | $1,506 |
| Penumbra, Inc. | 9 | $1,098 |
| Medtronic(2 entities) | 11 | $860 |
| Abbott | 10 | $689 |
| Recor Medical Inc | 3 | $339 |
| Cardiovascular Systems Inc. | 6 | $290 |
| Siemens Medical Solutions USA, Inc. | 1 | $164 |
| Inari Medical, Inc. | 2 | $158 |
| Heartflow, Inc. | 2 | $156 |
| Teleflex LLC | 1 | $142 |
| AstraZeneca | 1 | $111 |
| Bayer | 1 | $18 |
| Amgen | 1 | $17 |
| Z-medica, LLC | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Edwards SAPIEN 3 Transcatheter Heart Valve$16,588
- (9520) IGT Devices Undivided$15,397
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$12,441
- Spectranetics Undiv$10,458
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$9,200
- US Und$6,265
- (R11) US EQ Undivided$5,640
- AVVIGO Guidance System$2,699
- (6361) Core Mobile$2,350
- GENERAL - STRUCTURAL HEART$1,447
- GENERAL - THERAPIES$1,118
- SAPIEN 3 Ultra RESILIA$975
- (6574) Coronary Other$971
- Indigo System$968
- IGT Devices Und$940
- (6585) Omniwire$828
- Impella$569
- ONYX FRONTIER$453
- (6575) Coronary Undivided$431
- Orsiro Mission$429
How this compares
$118,717 in reported general payments places this provider in the 90th percentile of 182 interventional cardiology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 177 | $199,118 |
| EntrestoSacubitril/Valsartan | 118 | $124,933 |
| XareltoRivaroxaban | 14 | $21,604 |
| JardianceEmpagliflozin | 22 | $15,840 |
| Repatha SureclickEvolocumab | 12 | $8,909 |
| Ranolazine ErRanolazine | 30 | $3,770 |
| Metoprolol Succinate | 178 | $1,927 |
| Atorvastatin Calcium | 154 | $1,714 |
| Rosuvastatin Calcium | 110 | $1,315 |
| Carvedilol | 95 | $1,099 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 57 | $1,093 |
| Amlodipine Besylate | 132 | $1,058 |
| ClopidogrelClopidogrel Bisulfate | 124 | $977 |
| Bumetanide | 24 | $854 |
| Spironolactone | 125 | $781 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Saint Louis
- John LasalaSaint Louis$936K
- Harvey SerotaSaint Louis$752K
- Jasvindar SinghSaint Louis$696K
- Alan ZajariasSaint Louis$203K
- Anish ThomasSaint Louis$171K
- Gus TheodosSaint Louis$165K
- Prashanth ThakkerSaint Louis$129K
- George KichuraSaint Louis$118K
- Gil VardiSaint Louis$106K
- Anthony SonnSaint Louis$80K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.